Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
hannah.jones@ndm.ox.ac.uk

Research groups

Mass Spectrometry for Drug Target Discovery

Hannah Jones

Postdoctoral Researcher

Recent publications

Deubiquitinases in muscle physiology and disorders.
Journal article

Olie CS. et al, (2024), Biochem Soc Trans, 52, 1085 - 1098
Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1.
Journal article

Imhoff RD. et al, (2024), J Med Chem, 67, 4496 - 4524
Structural Premise of Selective Deubiquitinase USP30 Inhibition by Small-Molecule Benzosulfonamides.
Journal article

O'Brien DP. et al, (2023), Mol Cell Proteomics, 22
Structural Premise of Selective Deubiquitinase USP30 Inhibition by Small-Molecule Benzosulfonamides
Preprint

O’Brien DP. et al, (2022)
ABPP-HT*-Deep Meets Fast for Activity-Based Profiling of Deubiquitylating Enzymes Using Advanced DIA Mass Spectrometry Methods.
Journal article

Jones HBL. et al, (2022), Int J Mol Sci, 23

More publications